The DOI matches its Crossref record; 143 of the 143 references it cites were found in a registry or an index.
Cellular ADMA: Regulation and action
Open accessAbstract
Asymmetric (NG,NG) dimethylarginine (ADMA) is present in plasma and cells. It can inhibit nitric oxide synthase (NOS) that generates nitric oxide (NO) and cationic amino acid transporters (CAT) that supply intracellular NOS with its substrate, L-arginine from the plasma. Therefore, ADMA and its transport mechanisms are strategically placed to regulate endothelial function. This could have considerable clinical impact since endothelial dysfunction has been detected at the origin of hypertension and chronic kidney disease (CKD) in human subjects and may be a harbinger of large vessel disease and cardiovascular disease (CVD). Indeed, plasma levels of ADMA are increased in many studies of patients at risk for, or with overt CKD or CVD. However, the levels of ADMA measured in plasma of about 0.5 μmol · l−1 maybe below those required to inhibit NOS whose substrate, L-arginine, is present in concentrations manifold above the Km for NOS. However, NOS activity may be partially inhibited by cellular ADMA. Therefore, the cellular production of ADMA by protein arginine methyltransferase (PRMT) and protein hydrolysis, its degradation by NG, NG-dimethylarginine dimethylaminohydrolase (DDAH) and its transmembrane transport by CAT that determines intracellular levels of ADMA may also determine the state of activation of NOS. This is the focus of the review. It is concluded that cellular levels of ADMA can be 5- to 20-fold those in plasma and in a range that could tonically inhibit NOS. The relative importance of PRMT, DDAH and CAT for determining the intracellular NOS substrate: inhibitor ratio (L-arginine:ADMA) may vary according to the pathophysiologic circumstance. An understanding of this important balance requires knowledge of at least these three processes that regulate the intracellular levels of ADMA and arginine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arginine metabolism: nitric oxide and beyond
WU, G., & MORRIS, S. M. (1998) · Biochemical Journal · doi:10.1042/bj3360001 · Cited by 2,811
Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure
Leone, A., Moncada, S., Vallance, P., Calver, A., & Collier, J. (1992) · The Lancet · doi:10.1016/0140-6736(92)90865-z · Cited by 2,107
Inhibition of Translational Initiation by Let-7 MicroRNA in Human Cells
Pillai, R. S., Bhattacharyya, S. N., Artus, C. G., Zoller, T., Cougot, N., Basyuk, E., Bertrand, E., & Filipowicz, W. (2005) · Science · doi:10.1126/science.1115079 · Cited by 1,432
Relief of microRNA-Mediated Translational Repression in Human Cells Subjected to Stress
Bhattacharyya, S. N., Habermacher, R., Martine, U., Closs, E. I., & Filipowicz, W. (2006) · Cell · doi:10.1016/j.cell.2006.04.031 · Cited by 1,332
Zoccali, C., Bode-Böger, S. M., Mallamaci, F., Benedetto, F. A., Tripepi, G., Malatino, L. S., Cataliotti, A., Bellanuova, I., Fermo, I., Frölich, J. C., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)07217-8 · Cited by 1,087
Chang, J., Nicolas, E., Marks, D., Sander, C., Lerro, A., Buendia, M. A., Xu, C., Mason, W. S., Moloshok, T., Bort, R., et al. (2004) · RNA Biology · doi:10.4161/rna.1.2.1066 · Cited by 811
Endogenous Nitric Oxide Synthase Inhibitor: A Novel Marker of Atherosclerosis
Miyazaki, H., Matsuoka, H., Cooke, J. P., Usui, M., Ueda, S., Okuda, S., & Imaizumi, T. (1999) · Circulation · doi:10.1161/01.cir.99.9.1141 · Cited by 756
Albritton, L. M., Tseng, L., Scadden, D., & Cunningham, J. M. (1989) · Cell · doi:10.1016/0092-8674(89)90134-7 · Cited by 688
Lin, K. Y., Ito, A., Asagami, T., Tsao, P. S., Adimoolam, S., Kimoto, M., Tsuji, H., Reaven, G. M., & Cooke, J. P. (2002) · Circulation · doi:10.1161/01.cir.0000027109.14149.67 · Cited by 651
Achan, V., Broadhead, M., Malaki, M., Whitley, G., Leiper, J., MacAllister, R., & Vallance, P. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000081742.92006.59 · Cited by 593
Relationship Between Insulin Resistance and an Endogenous Nitric Oxide Synthase Inhibitor
Stühlinger, M. C. (2002) · JAMA · doi:10.1001/jama.287.11.1420 · Cited by 581
Transporters for Cationic Amino Acids in Animal Cells: Discovery, Structure, and Function
DEVÉS, R., & BOYD, C. A. R. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.2.487 · Cited by 499
Oxidative stress and nitric oxide deficiency in the kidney: a critical link to hypertension?
Wilcox, C. S. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00250.2005 · Cited by 481
Self-citationEndogenous Dimethylarginine as an Inhibitor of Nitric Oxide Synthesis
Vallance, P., Leone, A., Calver, A., Collier, J., & Moncada, S. (1992) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199204002-00018 · Cited by 469
Biological significance of endogenous methylarginines that inhibit nitric oxide synthases
Leiper, J. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00162-5 · Cited by 458
McDonald, K. K., Zharikov, S., Block, E. R., & Kilberg, M. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.50.31213 · Cited by 436
Regulation of Amino Acid and Glucose Transporters in Endothelial and Smooth Muscle Cells
Mann, G. E., Yudilevich, D. L., & Sobrevia, L. (2003) · Physiological Reviews · doi:10.1152/physrev.00022.2002 · Cited by 430
Surdacki, A., Nowicki, M., Sandmann, J., Tsikas, D., Boeger, R. H., Bode-Boeger, S. M., Kruszelnicka-Kwiatkowska, O., Kokot, F., Dubiel, J. S., & Froelich, J. C. (1999) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199904000-00020 · Cited by 426
Teerlink, T., Nijveldt, R. J., de Jong, S., & van Leeuwen, P. A. M. (2002) · Analytical Biochemistry · doi:10.1006/abio.2001.5575 · Cited by 417
Self-citationNitric oxide deficiency in chronic kidney disease
Baylis, C. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00424.2007 · Cited by 413
Kielstein, J. T., Impraim, B., Simmel, S., Bode-Böger, S. M., Tsikas, D., Frölich, J. C., Hoeper, M. M., Haller, H., & Fliser, D. (2004) · Circulation · doi:10.1161/01.cir.0000105764.22626.b1 · Cited by 401
Interference ofL-Arginine Analogues withL-Arginine Transport Mediated by the y+Carrier hCAT-2B
Closs, E. I., Basha, F. Z., Habermeier, A., & Förstermann, U. (1997) · Nitric Oxide · doi:10.1006/niox.1996.0106 · Cited by 385
Ravani, P., Tripepi, G., Malberti, F., Testa, S., Mallamaci, F., & Zoccali, C. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005010076 · Cited by 381
Böger, R. H. (2004) · The Journal of Nutrition · doi:10.1093/jn/134.10.2842s · Cited by 363
Ogawa, T., Kimoto, M., & Sasaoka, K. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)81786-0 · Cited by 360
Tizianello, A., De Ferrari, G., Garibotto, G., Gurreri, G., & Robaudo, C. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109771 · Cited by 359
Function and structure of heterodimeric amino acid transporters
Wagner, C. A., Lang, F., & Bröer, S. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.281.4.c1077 · Cited by 357
Abbasi, F., Asagmi, T., Cooke, J. P., Lamendola, C., McLaughlin, T., Reaven, G. M., Stuehlinger, M., & Tsao, P. S. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)02063-x · Cited by 354
Böger, R. H., Sullivan, L. M., Schwedhelm, E., Wang, T. J., Maas, R., Benjamin, E. J., Schulze, F., Xanthakis, V., Benndorf, R. A., & Vasan, R. S. (2009) · Circulation · doi:10.1161/circulationaha.108.838268 · Cited by 351
Dayoub, H., Achan, V., Adimoolam, S., Jacobi, J., Stuehlinger, M. C., Wang, B.-Y., Tsao, P. S., Kimoto, M., Vallance, P., Patterson, A. J., et al. (2003) · Circulation · doi:10.1161/01.cir.0000101924.04515.2e · Cited by 340
Palm, F., Onozato, M. L., Luo, Z., & Wilcox, C. S. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00998.2007 · Cited by 336
Self-citationCynober, L. A. (2002) · Nutrition · doi:10.1016/s0899-9007(02)00780-3 · Cited by 303
Organic ion transport during seven decades the amino acids
Christensen, H. N. (1984) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(84)90012-1 · Cited by 287
The transport of cationic amino acids across the plasma membrane of mammalian cells
White, M. F. (1985) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(85)90015-2 · Cited by 286
NIJVELDT, R. (2003) · Clinical Nutrition · doi:10.1054/clnu.2002.0613 · Cited by 256
Structure and Function of Cationic Amino Acid Transporters (CATs)
Closs, E. I., Boissel, J.-P., Habermeier, A., & Rotmann, A. (2006) · Journal of Membrane Biology · doi:10.1007/s00232-006-0875-7 · Cited by 249
Cardounel, A. J., Cui, H., Samouilov, A., Johnson, W., Kearns, P., Tsai, A.-L., Berka, V., & Zweier, J. L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m603606200 · Cited by 247
Endogenous nitric oxide synthase inhibitors are responsible for the L‐arginine paradox
Tsikas, D., Böger, R. H., Sandmann, J., Bode-Böger, S. M., & Frölich, J. C. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01686-0 · Cited by 237
Arginine, arginine analogs and nitric oxide production in chronic kidney disease
Baylis, C. (2006) · Nature Clinical Practice Nephrology · doi:10.1038/ncpneph0143 · Cited by 237
Traditional and emerging cardiovascular and renal risk factors: An epidemiologic perspective
Zoccali, C. (2006) · Kidney International · doi:10.1038/sj.ki.5000417 · Cited by 236
Sydow, K. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00617-x · Cited by 212
Asymmetric Dimethylarginine, Blood Pressure, and Renal Perfusion in Elderly Subjects
Kielstein, J. T., Bode-Böger, S. M., Frölich, J. C., Ritz, E., Haller, H., & Fliser, D. (2003) · Circulation · doi:10.1161/01.cir.0000060496.23144.a7 · Cited by 211
REGULATION OF CATIONIC AMINO ACID TRANSPORT: The Story of the CAT-1 Transporter
Hatzoglou, M., Fernandez, J., Yaman, I., & Closs, E. (2004) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.23.011702.073120 · Cited by 207
Böger, R. H., Maas, R., Schulze, F., & Schwedhelm, E. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.07.001 · Cited by 205
Concentration of dimethyl-L-arginine in the plasma of patients with end-stage renal failure
MacAllister, R. J., Rambausek, M. H., Vallance, P., Williams, D., Hoffmann, K.-H., & Ritz, E. (1996) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/11.12.2449 · Cited by 204
Tojo, A., Welch, W. J., Bremer, V., Kimoto, M., Kimura, K., Omata, M., Ogawa, T., Vallance, P., & Wilcox, C. S. (1997) · Kidney International · doi:10.1038/ki.1997.490 · Cited by 200
Self-citationMcDermott, J. R. (1976) · Biochemical Journal · doi:10.1042/bj1540179 · Cited by 192
Teerlink, T. (2005) · Vascular Medicine · doi:10.1177/1358836x0501000111 · Cited by 185
Self-citationIdentification of a low affinity, high capacity transporter of cationic amino acids in mouse liver.
Closs, E. I., Albritton, L. M., Kim, J. W., & Cunningham, J. M. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53209-9 · Cited by 182
Tarnow, L., Hovind, P., Teerlink, T., Stehouwer, C. D. A., & Parving, H.-H. (2004) · Diabetes Care · doi:10.2337/diacare.27.3.765 · Cited by 182
Self-citationArnal, J. F., Münzel, T., Venema, R. C., James, N. L., Bai, C. L., Mitch, W. E., & Harrison, D. G. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117957 · Cited by 181
Cytokines and Insulin Induce Cationic Amino Acid Transporter (CAT) Expression in Cardiac Myocytes
Simmons, W. W., Closs, E. I., Cunningham, J. M., Smith, T. W., & Kelly, R. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.20.11694 · Cited by 177
Zhang, W.-Z., Venardos, K., Chin-Dusting, J., & Kaye, D. M. (2006) · Hypertension · doi:10.1161/01.hyp.0000231509.27406.42 · Cited by 174
Brosnan, M. E., & Brosnan, J. T. (2004) · The Journal of Nutrition · doi:10.1093/jn/134.10.2791s · Cited by 169
Anderstam, B., Katzarski, K., & Bergström, J. (1997) · Journal of the American Society of Nephrology · doi:10.1681/asn.v891437 · Cited by 168
Asagami, T., Abbasi, F., Stuelinger, M., Lamendola, C., McLaughlin, T., Cooke, J. P., Reaven, G. M., & Tsao, P. S. (2002) · Metabolism · doi:10.1053/meta.2002.33349 · Cited by 164
Fernandez, J., Yaman, İ., Mishra, R., Merrick, W. C., Snider, M. D., Lamers, W. H., & Hatzoglou, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009714200 · Cited by 160
Wang, D., Iversen, J., Wilcox, C. S., & Strandgaard, S. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00236.x · Cited by 156
Self-citationHPLC analysis of ADMA and other methylated l-arginine analogs in biological fluids
Teerlink, T. (2006) · Journal of Chromatography B · doi:10.1016/j.jchromb.2006.07.024 · Cited by 155
Self-citationOgawa, T., Kimoto, M., & Sasaoka, K. (1987) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(87)90929-6 · Cited by 154
Nitric oxide synthase inhibitors and hypertension in children and adolescents
Goonasekera, C. D. A., Rees, D. D., Woolard, P., Frend, A. J., Shah, V., & Dillon, M. J. (1997) · Journal of Hypertension · doi:10.1097/00004872-199715080-00015 · Cited by 151
Regulation of Cytokine-Induced Nitric Oxide Synthesis by Asymmetric Dimethylarginine
Ueda, S., Kato, S., Matsuoka, H., Kimoto, M., Okuda, S., Morimatsu, M., & Imaizumi, T. (2003) · Circulation Research · doi:10.1161/01.res.0000052990.68216.ef · Cited by 148
Durante, W., Liao, L., Reyna, S. V., Peyton, K. J., & Schafer, A. I. (2001) · Circulation · doi:10.1161/01.cir.103.8.1121 · Cited by 148
Delles, C., Schneider, M. P., John, S., Gekle, M., & Schmieder, R. E. (2002) · American Journal of Hypertension · doi:10.1016/s0895-7061(02)02278-1 · Cited by 141
Arginine and Endothelial and Vascular Health
Gornik, H. L., & Creager, M. A. (2004) · Journal of Nutrition · doi:10.1093/jn/134.10.2880s · Cited by 135
Lajer, M., Tarnow, L., Jorsal, A., Teerlink, T., Parving, H., & Rossing, P. R. (2008) · Diabetes Care · doi:10.2337/dc07-1762 · Cited by 132
Self-citationSessa, W. C., Hecker, M., Mitchell, J. A., & Vane, J. R. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.21.8607 · Cited by 128
Schlaich, M. P., Parnell, M. M., Ahlers, B. A., Finch, S., Marshall, T., Zhang, W., & Kaye, D. M. (2004) · Circulation · doi:10.1161/01.cir.0000149748.79945.52 · Cited by 124
Lyons, D., Roy, S., Patel, M., Benjamin, N., & Swift, C. G. (1997) · Clinical Science · doi:10.1042/cs0930519 · Cited by 123
Horowitz, J. D., & Heresztyn, T. (2006) · Journal of Chromatography B · doi:10.1016/j.jchromb.2006.09.023 · Cited by 122
Holden, D. P., Cartwright, J. E., Nussey, S., & Whitley, G. S. J. (2003) · Circulation · doi:10.1161/01.cir.0000091083.61609.df · Cited by 117
Aslam, S., Santha, T., Leone, A., & Wilcox, C. S. (2006) · Kidney International · doi:10.1038/sj.ki.5001983 · Cited by 117
Self-citationSiroen, M. P. C., van Leeuwen, P. A. M., Nijveldt, R. J., Teerlink, T., Wouters, P. J., & den Berghe, G. V. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000155784.59297.50 · Cited by 117
Self-citationN., C., & J., C. (2002) · Diabetologia · doi:10.1007/s00125-002-0975-6 · Cited by 116
The Clinical Significance of Asymmetric Dimethylarginine
Siroen, M. P. C., Teerlink, T., Nijveldt, R. J., Prins, H. A., Richir, M. C., & van Leeuwen, P. A. M. (2006) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.26.061505.111320 · Cited by 116
Self-citationCloning and Characterization of a Brain-specific Cationic Amino Acid Transporter
Hosokawa, H., Sawamura, T., Kobayashi, S., Ninomiya, H., Miwa, S., & Masaki, Τ. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.13.8717 · Cited by 115
Insulin resistance: potential role of the endogenous nitric oxide synthase inhibitor ADMA
Sydow, K., Mondon, C. E., & Cooke, J. P. (2005) · Vascular Medicine · doi:10.1177/1358836x0501000106 · Cited by 114
Indices of activity of the nitric oxide system in hemodialysis patients
Schmidt, R. J., Domico, J. R., Samsell, L. S., et al. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70348-3 · Cited by 110
Hardy, T. A., & May, J. M. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00781-x · Cited by 108
Wang, D., Strandgaard, S., Iversen, J., & Wilcox, C. S. (2008) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.90506.2008 · Cited by 108
Self-citationExpression, regulation and function of carrier proteins for cationic amino acids
Closs, E. I. (2002) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200201000-00015 · Cited by 107
Regulation of eNOS-Derived Superoxide by Endogenous Methylarginines
Druhan, L. J., Forbes, S. P., Pope, A. J., Chen, C.-A., Zweier, J. L., & Cardounel, A. J. (2008) · Biochemistry · doi:10.1021/bi702377a · Cited by 104
Sobrevía, L., Yudilevich, D. L., & Mann, G. E. (1997) · The Journal of Physiology · doi:10.1113/jphysiol.1997.sp021916 · Cited by 104
Nijveldt, R. J. (2002) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/17.11.1999 · Cited by 104
Bogle, R., Baydoun, A. R., Pearson, J. D., & Mann, G. E. (1996) · The Journal of Physiology · doi:10.1113/jphysiol.1996.sp021138 · Cited by 103
Cardounel, A. J., Xia, Y., & Zweier, J. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m410241200 · Cited by 101
Hanai, K., Babazono, T., Nyumura, I., Toya, K., Tanaka, N., Tanaka, M., Ishii, A., & Iwamoto, Y. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn716 · Cited by 101
Lund, S. S., Tarnow, L., Stehouwer, C. D. A., Schalkwijk, C. G., Teerlink, T., Gram, J., Winther, K., Frandsen, M., Smidt, U., Pedersen, O. B., et al. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0815 · Cited by 101
Self-citationOnozato, M. L., Tojo, A., LEIPER, J. M., Fujita, T., Palm, F., & Wilcox, C. S. (2007) · Diabetes · doi:10.2337/db06-1772 · Cited by 100
Self-citationMasuda, H., Goto, M., Tamaoki, S., & Azuma, H. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702298 · Cited by 99
Homocysteine induces endothelial dysfunction via inhibition of arginine transport.
Jin, L., Caldwell, R. B., Li-Masters, T., & Caldwell, R. W. (2007) · PubMed · Cited by 95
Asymmetric dimethylarginine (ADMA): a key regulator of nitric oxide synthase
Böger, R. H., Vallance, P. J., & Cooke, J. P. (2003) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(03)00027-8 · Cited by 95
Fernandez, J., Bode, B., Koromilas, A. E., Diehl, J. A., Krukovets, I., Snider, M. D., & Hatzoglou, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110778200 · Cited by 93
Päivä, H., Lehtimäki, T. J., Laakso, J. T., Ruokonen, I., Rantalaiho, V. M., Wirta, O., Pasternack, A. I., & Laaksonen, R. (2003) · Metabolism · doi:10.1053/meta.2003.50048 · Cited by 90
Wang, D., Strandgaard, S., Børresen, M. L., Luo, Z., Connors, S. G., Yan, Q., & Wilcox, C. S. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2007.09.020 · Cited by 89
Self-citationYang, Z., Venardos, K. M., Jones, E., Morris, B. J., Chin-Dusting, J. P. F., & Kaye, D. M. (2007) · Circulation · doi:10.1161/circulationaha.106.665836 · Cited by 89
The asymmetrical dimethylarginine (ADMA)-multiple organ failure hypothesis
Nijveldt, R. J. (2003) · Clinical Nutrition · doi:10.1054/clnu.2002.0614 · Cited by 87
Transcriptional Control of the Arginine/Lysine Transporter, Cat-1, by Physiological Stress
Fernandez, J., Lopez, A. B., Wang, C., Mishra, R., Zhou, L., Yaman, İ., Snider, M. D., & Hatzolgou, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305903200 · Cited by 86
Ribeiro, A. M., Brunini, T. M., Ellory, J. C., & Mann, G. E. (2001) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00267-4 · Cited by 84
Wilcken, D. E. L., Sim, A. S., Wang, J., & Wang, X. L. (2007) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2007.04.017 · Cited by 82
Altınova, A. E., Arslan, M., Dinçel, A. S., Aktürk, M., Altan, N., & Törüner, F. B. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2643 · Cited by 80
N G , N G -Dimethylarginine and N G , N ' G -dimethylarginine in renal insufficiency
Banchaabouchi, M. A., Marescau, B., Possemiers, I. P., D’Hooge, R., Levillain, O., & Deyn, P. P. D. (2000) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s004240050973 · Cited by 79
Cationic amino acid transporter gene expression in cultured vascular smooth muscle cells and in rats
Hattori, Y., Kasai, K., & Gross, S. S. (1999) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1999.276.6.h2020 · Cited by 78
Durante, W., Liao, L., Iftikhar, I., et al. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.20.11838 · Cited by 76
Busch, M., Fleck, C., Wolf, G., & Stein, G. (2006) · Amino Acids · doi:10.1007/s00726-005-0268-8 · Cited by 75
Mittermayer, F., Mayer, B., Meyer, A. L., Winzer, C., Pacini, G., Wagner, O. F., Wolzt, M., & Kautzky‐Willer, A. (2002) · Diabetologia · doi:10.1007/s00125-002-0916-4 · Cited by 74
Reduced Nitric Oxide Concentration in the Renal Cortex of Streptozotocin-Induced Diabetic Rats
Palm, F., Buerk, D. G., Carlsson, P., Hansell, P., & Liss, P. (2005) · Diabetes · doi:10.2337/diabetes.54.11.3282 · Cited by 73
Self-citationYang, Z.-Y., & Kaye, D. M. (2008) · Human Mutation · doi:10.1002/humu.20891 · Cited by 70
l-Arginine transporters in cardiovascular disease: A novel therapeutic target
Chin-Dusting, J. P. F., Willems, L., & Kaye, D. M. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.08.001 · Cited by 69
Uremic levels of urea inhibit l -arginine transport in cultured endothelial cells
Xiao, S., Wágner, L., Mahaney, J. E., & Baylis, C. (2001) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2001.280.6.f989 · Cited by 68
In Vivo and In Vitro Evidence for Impaired Arginine Transport in Human Heart Failure
Kaye, D. M., Ahlers, B. A., Autelitano, D. J., & Chin-Dusting, J. P. F. (2000) · Circulation · doi:10.1161/01.cir.102.22.2707 · Cited by 68
Hormonal regulation of the gene for the type C ecotropic retrovirus receptor in rat liver cells
Wu, J. Y., Robinson, D. R., Kung, H., & Hatzoglou, M. (1994) · Journal of Virology · doi:10.1128/jvi.68.3.1615-1623.1994 · Cited by 68
Endogenous Methylarginines Regulate Neuronal Nitric-oxide Synthase and Prevent Excitotoxic Injury
Cardounel, A. J., & Zweier, J. L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108983200 · Cited by 67
Brunini, T. M. C., Mendes-Ribeiro, A., Ellory, J. C., & Mann, G. E. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.09.019 · Cited by 66
Xiao, S., Wagner, L. J., Schmidt, R. J., & Baylis, C. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.0590041466.x · Cited by 65
Palm, F., Friederich, M., Carlsson, P., Hansell, P., Teerlink, T., & Liss, P. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00166.2007 · Cited by 64
Self-citationMolecular Sites of Regulation of Expression of the Rat Cationic Amino Acid Transporter Gene
Aulak, K. S., Liu, J., Wu, J., Hyatt, S. L., Puppi, M., Henning, S., & Hatzoglou, M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.47.29799 · Cited by 63
Xiong, Y., Fu, Y., Fu, S., & Zhou, H. (2003) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200308000-00006 · Cited by 63
Role of Asymmetric Dimethylarginine in Inflammatory Reactions by Angiotensin II
Chen, M., Xie, X.-M., Yang, T., Wang, Y., Zhang, X., Bai-lin, L., & Li, Y. (2007) · Journal of Vascular Research · doi:10.1159/000103284 · Cited by 62
Teerlink, T., Neele, S. J. M., de Jong, S., Netelenbos, J. C., & Stehouwer, C. D. A. (2003) · Clinical Science · doi:10.1042/cs20020309 · Cited by 61
Self-citationPost, M. S., Verhoeven, M. O., van der Mooren, M. J., Kenemans, P., Stehouwer, C. D. A., & Teerlink, T. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030584 · Cited by 58
Self-citationMittermayer, F., Namiranian, K., Pleiner, J., Schaller, G., & Wolzt, M. (2004) · Clinical Science · doi:10.1042/cs20030363 · Cited by 56
Ellger, B., Richir, M. C., van Leeuwen, P. A. M., Debaveye, Y. A., Langouche, L., Vanhorebeek, I., Teerlink, T., & den Berghe, G. V. (2008) · Endocrinology · doi:10.1210/en.2007-1558 · Cited by 56
Self-citationGonzález, M., Flores, C. A., Pearson, J., Casanello, P. C., & Sobrevía, L. (2004) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-004-1261-x · Cited by 52
Role of asymmetric dimethylarginine for angiotensin II-induced target organ damage in mice
Jacobi, J., Maas, R., Cordasic, N., Koch, K., Schmieder, R. E., Böger, R. H., & Hilgers, K. F. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01103.2007 · Cited by 50
Asymmetrical dimethylarginine plasma clearance persists after acute total nephrectomy in rats
Carello, K. A., Whitesall, S. E., Lloyd, M. C., Billecke, S. S., & D’Alecy, L. G. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00208.2005 · Cited by 46
Nijveldt, R. J., Teerlink, T., van der Hoven, B., Siroen, M., Kuik, D. J., Rauwerda, H., & van Leeuwen, P. (2003) · Critical Care · doi:10.1186/cc1915 · Cited by 45
Self-citationPedersen, L. G., Tarnow, I., Olsen, L. H., Teerlink, T., & Pedersen, H. D. (2005) · Research in Veterinary Science · doi:10.1016/j.rvsc.2005.07.005 · Cited by 44
Self-citationSchwartz, I. F., Ayalon, R., Chernichovski, T., Reshef, R., Chernin, G., Weinstein, T., Litvak, A., Levo, Y., & Schwartz, D. (2006) · Kidney International · doi:10.1038/sj.ki.5000067 · Cited by 43
Okubo, K., Hayashi, K., Wakino, S., Matsuda, H., KUBOTA, E., Honda, M., Tokuyama, H., Yamamoto, T., Kajiya, F., & Saruta, T. (2005) · Hypertension Research · doi:10.1291/hypres.28.181 · Cited by 42
Richir, M. C., Bouwman, R. H., Teerlink, T., Siroen, M. P. C., de Vries, T. P. G. M., & van Leeuwen, P. A. M. (2008) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607108321702 · Cited by 39
Self-citationSmulders, R. A., Aarsen, M., Teerlink, T., VRIES, P. M. J. M. D., van Kamp, G. J., Donker, A. J. M., & Stehouwer, C. D. A. (1997) · Clinical Science · doi:10.1042/cs0920367 · Cited by 37
Self-citationWang, J., Sim, A. S., Wang, X. L., & Wilcken, D. E. L. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-006-6271-8 · Cited by 37
Decreased levels of asymmetric dimethylarginine during acute hyperinsulinemia
Eid, H. M. A., Reims, H. M., Arnesen, H., Kjeldsen, S. E., Lyberg, T., & Seljeflot, I. (2007) · Metabolism · doi:10.1016/j.metabol.2006.11.003 · Cited by 37
Marcovecchio, M. L., Widmer, B., Dunger, D. B., & Dalton, R. N. (2008) · Clinical Science · doi:10.1042/cs20080079 · Cited by 31
Liu, J., & Hatzoglou, M. (1998) · Amino Acids · doi:10.1007/bf01320897 · Cited by 30
Sakurada, M., Shichiri, M., Imamura, M., et al. (2008) · Hypertension · doi:10.1161/hypertensionaha.108.114207 · Cited by 27
Asymmetric Dimethylarginine and Kidney Disease—Marker or Mediator?
Vallance, P. J., & LEIPER, J. M. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005050539 · Cited by 26
The effect of mild endotoxemia during low arginine plasma levels on organ blood flow in rats
Prins, H. A., Houdijk, A. P. J., Wiezer, M. J., Teerlink, T., van Lambalgen, A. A., THIJS, L. G., & van Leeuwen, P. A. M. (2000) · Critical Care Medicine · doi:10.1097/00003246-200006000-00051 · Cited by 25
Self-citationDetrimental effect of oxidized LDL on endothelial arginine metabolism and transportation
Zhang, W., Venardos, K. M., Finch, S., & Kaye, D. M. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.10.027 · Cited by 24
Bunck, M. C. M., Giltay, E. J., Diamant, M., Gooren, L. J., & Teerlink, T. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.01.020 · Cited by 17
Self-citationMoesgaard, S. G., Pedersen, L. G., Teerlink, T., Häggström, J. U., & Pedersen, H. D. (2005) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.2005.tb02750.x · Cited by 15
Self-citationAdma: a critical cardio‐renal link in heart failure?
Zoccali, C. (2003) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2003.01150.x · Cited by 9
Cited by
Endothelial dysfunction and vascular disease - a 30th anniversary update
Vanhoutte, P. M., Shimokawa, H., Feletou, M., & Tang, E. H. C. (2017) · Acta Physiologica · doi:10.1111/apha.12646 · Cited by 937
“Published by John Wiley & Sons Ltd, doi: 10.1111/apha.1264634 diovascular diseases (Knipp 2006, Palm et al. 2007, Teerlink et al. 2009, Antoniades et al. 2011, Wilcox 2012, Ghebremariam et al. 2013).”
InfluentialClinical Relevance of Biomarkers of Oxidative Stress
Frijhoff, J., Winyard, P. G., Zarkovic, N., Davies, S. S., Stocker, R., Cheng, D., Knight, A. R., Taylor, E. L., Oettrich, J., Ruskovska, T., et al. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2015.6317 · Cited by 909
MELAS syndrome: Clinical manifestations, pathogenesis, and treatment options
El-Hattab, A. W., Adesina, A. M., Jones, J., & Scaglia, F. (2015) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2015.06.004 · Cited by 610
Rochette, L., Lorin, J., Zeller, M., Guilland, J.-C., Lorgis, L., Cottin, Y., & Vergely, C. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.07.004 · Cited by 456
Carlström, M., Persson, A. E. G., Larsson, E., Hezel, M., Scheffer, P. G., Teerlink, T., Weitzberg, E., & Lundberg, J. O. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvq366 · Cited by 261
Self-citation
Metadata
- Authors
- Teerlink, T., Luo, Z., Palm, F., & Wilcox, C. S.
- Venue
- Pharmacological Research
- Publisher
- Elsevier BV
- Published
- 2009-12
- Volume
- 60
- Issue
- 6
- Pages
- 448-460
- ISSN
- 1043-6618 (ISSN-L)
- OpenAlex
- W2063382200
- Cited by
- 342
- References
- 143
- FWCI
- 11.81
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.